Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study (Q38815337)
Jump to navigation
Jump to search
scientific article published on October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study |
scientific article published on October 2016 |
Statements
1 reference
Secukinumab for Long-Term Treatment of Psoriatic Arthritis: A Two-Year Followup From a Phase III, Randomized, Double-Blind Placebo-Controlled Study (English)
1 reference
Arthur Kavanaugh
1 reference
Philip J Mease
1 reference
Andreas M Reimold
1 reference
Hasan Tahir
1 reference
Jürgen Rech
1 reference
Stephen Hall
1 reference
Piet Geusens
1 reference
Zailong Wang
1 reference
Luminita Pricop
1 reference
Shephard Mpofu
1 reference
FUTURE-1 Study Group
1 reference
1 October 2016
1 reference
1 reference
69
1 reference
3
1 reference
347-355
1 reference
Identifiers
1 reference
1 reference